Risk of severe COVID-19 in hypertensive patients treated with renin-angiotensin-aldosterone system inhibitors
Rafael Golpe, Luis A. Pérez‐de‐Llano, David Dacal, Héctor Guerrero-Sande, Beatriz Pombo-Vide, Pablo Ventura-Valcárcel
Topics & Concepts
MedicineRetrospective cohort studyInternal medicineRenin–angiotensin systemCoronavirus disease 2019 (COVID-19)Diabetes mellitusAldosteroneEndocrinologyBlood pressureDiseaseInfectious disease (medical specialty)COVID-19 Clinical Research StudiesLong-Term Effects of COVID-19Pharmacological Receptor Mechanisms and Effects